Lienz, Austria
Lienz, Austria

Time filter

Source Type

News Article | May 17, 2017
Site: marketersmedia.com

A Richmond doctors has launched a new site advertising its services for patients in the local area. The professional practice, called Roseneath Medical Practice, has an experienced team of GPs on hand to help patients with all of their medical needs. They pride themselves on their friendly service, and put patients’ needs as their number one priority. More information can be found at: http://roseneathdoctorsrichmond.co.uk. The practice is located in Richmond upon Thames, and offers same day appointments, fast test results, an an extensive range of services to help offer the widest range of health services for patients nearby. On the practice website, visitors can discover that Rosenheath takes pride in searching beneath the surface in order to identify the root cause of whatever is bothering the patient. This means that they strive to go the extra mile in finding out what’s wrong, and that they don’t just treat the symptoms. Often, patients can feel that they are not given sufficient time when the visit the doctors. This can make it feel like they are more of a statistic than a human being in some cases. Rosenheath’s aim is for its patients to receive the time and attention they deserve. As part of this philosophy, the practice refuses to treat prescription medication as a cure-all remedy, and instead places the focus and concentration on various aspects of prevention. As part of this process, the Richmond based doctors practice strives to empower its patients, allowing them to realise their maximum health potential. A strong foundation in this approach to healthcare is the practice itself, which is relaxed and spacious, as well as offering a comfortable place for the patients to relax and receive their treatment. Some of the benefits of signing up with Rosenheath include convenient consultation times, same-day appointments, and immediate prescriptions. In addition to this, most test results are available within 24 hours. Full details of the services offered by the practice, and the benefits it can offer, can be found on the URL above. For more information, please visit http://roseneathdoctorsrichmond.co.uk/


News Article | May 20, 2017
Site: marketersmedia.com

In a slightly different approach to launching its new video production service, Branded Web Presence, a Marketing Agency in Dallas Texas has decided it will give away 25 personalized one-year marketing plans, during the month of June. Where most businesses tend to just buy online banners or hire a telemarketer, Branded Web Presence has decided to be a little more creative with the start of its new business and medical practice website video production service. Bob Bare, Founder and Creative Director at Branded Web Presence, says: “We wanted to be creative with the launch of our new website video production service for businesses and medical practices because we wanted to do something memorable, that will be a valuable and lasting contribution. It should be really worthwhile and we’re hoping it will result in giving Doctors and business owners a big picture of how they can expand their practice/business. It should go great unless hundreds of millions of people just stop watching YouTube and go back to standard TV (won’t happen)!” Branded Web Presence has always made a point of standing out when compared to other Marketing Agencies in the Dallas Texas area. This launch celebration is just one of the many ways it does so. This is a great chance for Dallas Texas CEOs and Medical Practice owners to discover fresh ideas on how to grow and expand, regardless of their specialty, and support Branded Web Presence, a digital marketing and reputation management agency created to assist them become more visible online. Branded Web Presence has been serving the Dallas Texas area since 2016. To date it has served over 100 customers and has become recognized for being run by one of only a handful of Certified Guerrilla Marketing Trainers worldwide, trained and certified by the late Jay Conrad Levinson.. It can be found on Westmoreland near the corner of Jefferson and Westmoreland, although Mr. Bare usually likes to meet at the business or practice to understand its needs better. Bob Bare also said: “While Branded Web Presence may not be the only business with this kind of offering, local practices are choosing Branded Web Presence because Bob is an experienced entrepreneur, past Rotary president, and understands how business models and marketing need to work together..” When asked about the new business/ medical practice video production service, Bob Bare said: “We think it’s going to be a hit because almost everyone has been told they need to use video on their website and post videos on Facebook and YouTube, but most people don’t know where to start.”. Further information about Branded Web Presence and the new business and medical practice website video production service can be discovered at http://BrandedWebPresence.com, or call (972) 567-7376, to contact Bob Bare, who specializes in Providing Business and Medical Practitioners More Visibility Online For more information, please visit http://www.brandedwebpresence.com


News Article | May 22, 2017
Site: www.pressat.co.uk

I think it is very important that people who are living with tinnitus are able to share their own experiences and meet other people 22/05/2017 A new group to support local people with tinnitus is being formed in Salisbury, Wiltshire. The first meeting will take place on Wednesday 7 June 2017, 1.30-3.30pm at the Salisbury Medical Practice, Fisherton House, Fountain Way, Salisbury, SP2 7FD. The group is being organised by Katy Gillingham, Health Promotion Assistant at Salisbury Medical Practice, who says: “We are very excited to host a Tinnitus Support Cafe here at Salisbury Medical Practice. I think it is very important that people who are living with tinnitus are able to share their own experiences and meet other people in a similar situation to themselves in a relaxed environment. Refreshments will be provided and there is no need to book, just drop in!” Dave Carr, BTA Volunteering and Engagement Manager comments: “Being among people who have the problem, listening to their experiences and how they have managed to handle things, is a tremendous help for the individual. I witness this first hand when attending group meetings. It is amazing seeing the difference it makes to people, especially those who have recently been diagnosed.” Tinnitus is defined as the experience of sounds with no external source, most commonly ringing or buzzing, but sometimes experienced as whooshing, clicking or even music. Many people aren’t troubled by sounds they hear, but for around 10%, the condition has a significant impact on their quality of life, often linked to stress, anxiety or sometimes depression. Dave adds: “Tinnitus can be an isolating condition, with friends and family struggling to understand how it feels to adapt to the presence of loud or persistent noises. Some people choose to bring a partner or family member to the meetings, which can often help both parties understand more about the condition and the experiences or behaviours it can bring.” If you would like to find out more, please contact Katy Gillingham on 01722 333 034 or [email protected] Case studies and experts are available for interview/photo opportunities to support this story. The British Tinnitus Association (BTA) is an independent charity which supports thousands of people who experience tinnitus and advises medical professionals from across the world. The BTA is the primary source of support and information for people with tinnitus in the UK, facilitating an improved quality of life. They aim to encourage prevention through its educational programme and to seek effective treatment for tinnitus through a medical research programme. The support the BTA offers to 335,000 people per year who are affected by tinnitus is reliant upon the generous donations of their supporters and fundraisers. They receive no government support and need to raise half a million pounds each year to continue their UK wide support. Donations can be made via www.justgiving.com/BTA Not an illness or disease, tinnitus is a term that describes the sensation of hearing a noise in the absence of an external sound. The noise can have virtually any quality. Ringing, whistling, and buzzing are common, but more complex sounds may also be reported. Troublesome tinnitus can be very distressing for the affected individual, and issues may arise with sleep, concentration and mood. However, in many cases, subtle changes in people’s environment can address these issues, and improve quality of life. The experienced team at the BTA understands the impact that tinnitus can have on the lives of those who experience tinnitus and those who live with them, so seeks to provide the most appropriate and expert advice and information free of charge – via a confidential freephone helpline on 0800 018 0527 and online at www.tinnitus.org.uk. The BTA can also post printed and audio information and advice. Visit the BTA’s Facebook page at www.facebook.com/BritishTinnitusAssociation and follow the BTA on Twitter at www.twitter.com/BritishTinnitus


— Global Nicotine Gum Industry Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Companies profiled in this report are Novartis, Perrigo Company, Pharmacia, Fertin Pharma, Revolymer, Johnson & Johnson, Alchem International, Cambrex Corporation, GlaxoSmithKline, Reynolds American, Dr. Reddy's Laboratories in terms of Basic Information, Manufacturing Base, Sales Area and Its Competitors, Sales, Revenue, Price and Gross Margin (2012-2017). Split by Product Types, with sales, revenue, price, market share of each type, can be divided into • 2 mg/piece of gum dosage • 4 mg/piece of gum dosage Split by applications, this report focuses on sales, market share and growth rate of Nicotine Gum in each application, can be divided into • Withdrawal Clinics • Medical Practice • Individual Smokers • Others Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/424367 Table of Content: 1 Nicotine Gum Market Overview 2 Global Nicotine Gum Sales, Revenue (Value) and Market Share by Manufacturers 3 Global Nicotine Gum Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 4 Global Nicotine Gum Manufacturers Profiles/Analysis 5 North America Nicotine Gum Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 6 Latin America Nicotine Gum Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 7 Europe Nicotine Gum Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 8 Asia-Pacific Nicotine Gum Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 9 Middle East and Africa Nicotine Gum Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 10 Nicotine Gum Manufacturing Cost Analysis 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 13 Market Effect Factors Analysis 14 Global Nicotine Gum Market Forecast (2017-2022) 15 Research Findings and Conclusion 16 Appendix Inquire more for more details about this report at: https://www.themarketreports.com/report/ask-your-query/424367 For more information, please visit https://www.themarketreports.com/report/2017-2022-global-top-countries-nicotine-gum-market-report


Entech Hosts Free Panel Discussion on IT Security for Small Business and Medical Practice Owners Join Entech from 12 to 1 p.m. on Mar. 23, 2017 for this valuable one-hour panel session and learn about IT security for a business or medical practice. A $495 value, seating is limited and free to the first 100 people who register. Register now at https://www.eventbrite.com/e/it-security-and-what-it-means-to-your-business-or-medical-practice-registration-31836558002?discount=Compliments_of_Entech to reserve a spot. Fort Myers, FL, February 22, 2017 --( According to SmallBizTrends.com: * 43% of cyber attacks target small business * 60% of small companies got out of business within six months of an attack * 50% report that data breaches involve customer and employee data Join Entech from 12 to 1 p.m. on Mar. 23, 2017 for this valuable one-hour panel session and learn about IT security for a business or medical practice. Participants will learn about: * Current threats to their organizations * What they need to know about physical vs digital security * Industry-specific compliance, such as HIPAA * and more... Panelists include well-known industry security experts, including: * Chris Brenes, Director of IT and Security, Entech * Rob Krug, Senior Solution Architect, Sonicwall * Lee Adams, PMP, QSA, CHPSE, CCSFP, President, Tampa Bay Compliance Panel Discussion Registration--Act Now! A $495 value, seating is limited and free to the first 100 people who register. Register now at https://www.eventbrite.com/e/it-security-and-what-it-means-to-your-business-or-medical-practice-registration-31836558002?discount=Compliments_of_Entech to reserve a spot. About the Panelists Chris Brenes is Director of IT and Security for Entech (www.entechUS.com). He holds multiple certifications security certifications, including a Certified Ethical Hacking (CEH) Certification, Certified Information Systems Security Professional (CISSP) certification and the CompTIA Security+ certification. Rob Krug is a Senior Solution Architect for SonicWall (www.sonicwall.com). Krug is an ethical hacker that has been in the network security space for more than 25 years. In addition to having many certifications in networking and security disciplines, he is a SonicWall Master CSSA. Krug has an extensive background in network design, engineering, security, and telecommunications, and is also a past SonicWall System Engineer of the Year recipient. Lee Adams is President of Tampa Bay Compliance (www.tampabaycompliance.com). She is an experienced IT security professional and auditor providing consulting services to covered entities on all aspects of HIPAA/HITECH Privacy and Security Compliance. She holds various certifications, including: Project Manager Professional; Qualified Security Assessor; and Certified HIPAA Privacy Security Expert. About Entech Entech - with locations in Fort Myers and Bradenton, FL - is a full-service technology solution provider specializing in IT managed services for businesses ranging from 20 to 100+ users. Entech’s managed services include: · Security - Network and system security, compliance, anti-virus, anti-threat · Business Continuity - Data back up and recovery, disaster recovery planning, data security · IT Planning - Cost containment, lifecycle and threat management · Infrastructure - Cloud services, virtualization, mobile computing For more information, visit www.entechUS.com. Fort Myers, FL, February 22, 2017 --( PR.com )-- IT security is critical for small businesses and medical practices. It can mean the difference between a growing, healthy business or one just waiting for a cyber attack.According to SmallBizTrends.com:* 43% of cyber attacks target small business* 60% of small companies got out of business within six months of an attack* 50% report that data breaches involve customer and employee dataJoin Entech from 12 to 1 p.m. on Mar. 23, 2017 for this valuable one-hour panel session and learn about IT security for a business or medical practice.Participants will learn about:* Current threats to their organizations* What they need to know about physical vs digital security* Industry-specific compliance, such as HIPAA* and more...Panelists include well-known industry security experts, including:* Chris Brenes, Director of IT and Security, Entech* Rob Krug, Senior Solution Architect, Sonicwall* Lee Adams, PMP, QSA, CHPSE, CCSFP, President, Tampa Bay CompliancePanel Discussion Registration--Act Now!A $495 value, seating is limited and free to the first 100 people who register. Register now athttps://www.eventbrite.com/e/it-security-and-what-it-means-to-your-business-or-medical-practice-registration-31836558002?discount=Compliments_of_Entech to reserve a spot.About the PanelistsChris Brenes is Director of IT and Security for Entech (www.entechUS.com). He holds multiple certifications security certifications, including a Certified Ethical Hacking (CEH) Certification, Certified Information Systems Security Professional (CISSP) certification and the CompTIA Security+ certification.Rob Krug is a Senior Solution Architect for SonicWall (www.sonicwall.com). Krug is an ethical hacker that has been in the network security space for more than 25 years. In addition to having many certifications in networking and security disciplines, he is a SonicWall Master CSSA. Krug has an extensive background in network design, engineering, security, and telecommunications, and is also a past SonicWall System Engineer of the Year recipient.Lee Adams is President of Tampa Bay Compliance (www.tampabaycompliance.com). She is an experienced IT security professional and auditor providing consulting services to covered entities on all aspects of HIPAA/HITECH Privacy and Security Compliance. She holds various certifications, including: Project Manager Professional; Qualified Security Assessor; and Certified HIPAA Privacy Security Expert.About EntechEntech - with locations in Fort Myers and Bradenton, FL - is a full-service technology solution provider specializing in IT managed services for businesses ranging from 20 to 100+ users. Entech’s managed services include:· Security - Network and system security, compliance, anti-virus, anti-threat· Business Continuity - Data back up and recovery, disaster recovery planning, data security· IT Planning - Cost containment, lifecycle and threat management· Infrastructure - Cloud services, virtualization, mobile computingFor more information, visit www.entechUS.com. Click here to view the list of recent Press Releases from Entech


News Article | February 23, 2017
Site: www.prweb.com

CALNOC, the nation’s first and only nursing quality indicators database today announced Gary Kaplan, MD, FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on October 23, 2017. Dr. Gary Kaplan has served as the chairman and CEO of the Virginia Mason Health System in Seattle since 2000. In addition to his role at Virginia Mason, Dr. Kaplan also serves as the chair of the Institute of Healthcare Improvement Board of Directors and chairman of the National Patient Safety Foundation Lucian Leape Institute. Dr. Kaplan has been elected to membership in the Institute of Medicine, one of the highest honors in the field of health and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service. Modern Healthcare Magazine ranked Dr. Kaplan No. 11 on its 2016 list of the 50 Most Influential Physician Executives in the U.S., this will be the 11th time he has made it on this prestigious annual list. Dr. Kaplan has been awarded John M. Eisenberg Patient Safety and Quality Award from the National Quality Forum and the Joint Commission for improving patient safety and health care quality. In addition, he also received the Harry J. Harwick Lifetime Achievement Award from the Medical Group Management Association and the American College of Medical Practice Executives in recognition of this contributions to health care. Dr. Kaplan received his degree in medicine from the University of Michigan and is board certified in internal medicine which he currently practices at Virginia Mason. He is recognized as one of the most influential physician executives in health care. “We are extremely pleased to have Gary Kaplan Keynote the 2017 CALNOC Conference”, said Tony Sung, Chief Executive Officer for CALNOC. “His commitment to excellence in patient safety and health care quality are well known everywhere. We look forward to his insights and knowledge as he addresses the CALNOC conference attendees”. CALNOC’s 2017 Conference will focus on empowering nursing and providing value by measuring nursing impact in healthcare through collaboration. The CALNOC Conference will examine evidence-based insights, best practices and emerging CALNOC nursing-sensitive data findings to assist nursing and quality leadership in advancing patient care excellence. CALNOC’s Conference- Empowerment, Value and Collaboration - will be held on October 22-24 in Seattle at the Renaissance Hotel. The Collaborative Alliance for Nursing Outcomes (CALNOC), is the leading provider of Business Intelligence, and Research on nurse sensitive quality indicators. CALNOC serves as the nation’s only nurse sensitive registry owned, managed, operated and designed by nursing. Always on the forefront of patient care excellence, CALNOC created the first database registry of nurse sensitive indicators which turns data into powerful information for hospital executives to guide decisions to advance global patient care excellence. CALNOC is a non-profit 501 (c) (3) public benefit corporation with headquarters in San Ramon, California. For more information, call 888-586-1994 or visit http://www.calnoc.org


News Article | November 30, 2016
Site: globenewswire.com

TORONTO, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Dr. Patricio Stocker, President and CEO of PharmaCielo Ltd., announced the company has appointed a Medical Advisory Board (MAB) to provide guidance on the development of medicinal-grade cannabis oil extracts and related products appropriate for use by clinical practitioners. “Under the guidance of Dr. Delon Human, PharmaCielo Board of Directors member and Chair of the MAB, appointees will be able to provide significant input in the development of our medicinal-grade products through their ability to provide global expertise in the areas of healthcare policy, regulation, medical science and patient insights in addition to their clinical experience,” said Dr. Stocker. Dr. Human has assembled an experienced team of international medical clinicians whose expertise will be leveraged to provide guidance in the development of medicinal-grade cannabis oil based products, as well as international insight and understanding of worldwide healthcare policy and its implications for this emerging global industry. “The Medical Advisory Board will oversee PharmaCielo’s practices and processes, ensuring they are UN-aligned and performed ethically and according to Good Manufacturing and Good Medical Practice,” said Dr. Human.  “During the April 2016 UN General Assembly Special Session on Drugs, the UN and its member states strongly endorsed the need to ensure the accessibility and availability of internationally controlled drugs for medical and scientific purposes, including substances such as cannabinoids. In developing a global framework, this should be promoted within national legal systems, while simultaneously preventing diversion, abuse and trafficking. PharmaCielo has the opportunity to develop the world’s finest quality, naturally grown, pharma-grade cannabis oils.” Four appointees to the MAB were introduced (full biographies are available at www.pharmacielo.com): Dr. Delon Human is the president and CEO of Health Diplomats, a health advisory and consulting practice, providing strategic and technical advice on global health issues to Fortune 500 companies in the pharmaceutical, food, tobacco, nicotine and medical device industries as well as NGOs, governments and foundations. He has acted as adviser to WHO Director-Generals and UN Secretary-General Ban Ki Moon. He is a published author and specializes in global health strategy, corporate and product transformation, harm reduction and health communication. Formerly, he served as the Secretary-General of the International Food and Beverage Alliance (IFBA), which brings together the top food companies in the world. From 1997 to 2005, Dr. Human served as secretary general of the World Medical Association (WMA), the global representative body for physicians. He was instrumental in the establishment of the World Health Professions Alliance, an alliance of the global representative bodies of physicians, nurses, pharmacists, dentists and physical therapists. Dr. Human qualified as a physician in South Africa and completed his postgraduate studies in family medicine and child health in South Africa and Oxford, England. He was a clinician for two decades, part of the pediatric endocrinology research unit at the John Radcliffe Hospital and was involved in the establishment of several medical centers, a hospital and emergency clinic in South Africa. His business studies (MBA) were completed at the Edinburgh Business School. A former chair of the World Medical Association, Dr. Anders Milton is a highly sought-after consultant within the healthcare sector and has served as president of the European Regional Network on HIV/AIDS (ERNA) and as president of the Swedish Red Cross among a number of other positions, including appointment by the Swedish government as chairman of a committee on Swedish HIV/AIDS policies and a member of the Catastrophe Commission formed following the December 2004 tsunami. Recently he led a select committee studying organ donation and transplantation. Previously, Dr. Milton served as president and CEO of the Swedish Medical Association. A director of several public and privately held companies and foundations, Dr. Milton originally studied economics before turning to medicine, and after graduating university as a medical doctor and PhD he served as a clinician at the Department of Nephrology at the University Hospital at Uppsala. Throughout his career he has been engaged in work in support of human rights, ethics of medical practice and safe health care, of which effective pharmacotherapy is an integral part. Dr. Gutiérrez is a neuroradiologist in private practice and Director of the Neuroradiology Division at Centro Avanzado de Diagnostíco Médico (CEDIMED) in Colombia. Previously, Dr. Gutiérrez served at the University of Texas Health Science Center in San Antonio, TX as Associate Professor of Radiology, Vice Chair of Clinical Operations, Medical Director and Director of the Clinical Trials Division at the Radiology Department. He was formerly Director of Medical Development, Diagnostic Imaging and Associate Director of Clinical Development, Diagnostic Imaging for Bayer Healthcare (formerly Berlex Laboratories) in Montville, NJ. Dr. Gutiérrez also served as a medical monitor with Novartis (formerly Ciba-Geigy Labs) in Medellin. Dr. Gutiérrez has been the recipient of several awards for his work, and has been the lead researcher, international researcher and co-investigator on numerous clinical trials.  Regularly published, he has co-edited five medical books and authored or co-authored over 25 book chapters as well as 17 peer-reviewed articles and scores of abstracts and articles published in scientific research journals. Dr. Gutiérrez received a Doctorate in Medicine and Surgery from CES University in Medellin and Specialist in Clinical Radiology from Pontifical Xavierian University / San Ignacio Hospital in Bogota. He completed a research fellowship in Neuroradiology at Thomas Jefferson University / TJU Hospital in Philadelphia, PA and a visiting fellowship in Interventional Neuroradiology at the University of Miami / Jackson Memorial Hospital. Dr. Soto is Chairman of the Department of Radiology at Boston Medical Center and a Professor of Radiology at the Boston University School of Medicine. He has previously served as a general medical practitioner with the Hospital San Antonio de Prado in Colombia, section head of Body Imaging at University of San Vicente de Paúl Hospital, radiologist at CEDIMED in Medellin, assistant professor of Radiology at the University of Antioquia and was vice chairman of Boston Medical Center’s Department of Radiology for ten years. A native of Medellin with citizenship in both Colombia and the United States, Dr. Soto received his Doctor in Medicine and Surgery and Specialist in Diagnostic Radiology from CES University’s Health Sciences Institute in Medellin, and completed a Radiology Body Imaging Fellowship at Boston University Medical Center. Dr. Soto has received honors and awards from the Colombian Ministry of Education, Medellin Medicine Academy, Boston University Medical Center and numerous professional societies.  An extensively published researcher, Dr. Soto is a member of the editorial boards of Radiology and Abdominal Imaging, has edited seven books and has published over 85 original research papers and more than 35 reviews, book chapters and case reports. PharmaCielo Ltd. (the “Company”) is a global company privately held and headquartered in Canada, with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors.  The Company’s principal (and wholly-owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its Nursery and Propagation Centre located in Rionegro, Colombia. The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise.  PharmaCielo recognized the significant role that Colombia’s ideal location will play in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, has built a compelling business plan focused on supplying the international marketplace. This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as demand for the Company’s products, currency exchange changes and risks, internal funding and the financial condition of the Company, product roll-out, competition, technological changes, and other commercial matters involving the Company, its products, and the markets in which the Company operates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in subsequent reports should be consulted.


News Article | December 5, 2016
Site: www.24-7pressrelease.com

MAGNOLIA, TX, December 05, 2016-- Dr. Robert Ohsfeldt has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.A health economist and educator, Dr. Ohsfeldt celebrates a career in higher education that began in 1979. Noteworthy roles he has held throughout his tenure include research economist for the American Medical Association, health economics research scientist with Eli Lilly and Co., professor for the College of Public Health at the University of Iowa, research associate for the Southwest Center for Urban Research, and assistant professor for Arizona State University. Today, Dr. Ohsfeldt is a professor at the School of Public Health at Texas A&M University at College Station, which is a role he assumed in 2005, where currently serves as chair of the PhD program in health services research. Considered an expert in health economics and outcomes research, he has met with success by continuing with professional development over the years. He is a member of the American Society of Health Economists, the International Health Economic Association, the International Society of Pharmacoeconomics and Outcomes Research, and the Academy of Managed Care Pharmacy.In recognition of professional excellence, Dr. Ohsfeldt recently was named as a Regents Professor by the Texas A&M University System. The Regents Professor Award honors individuals at the rank of professor or equivalent whose performance as faculty members not only to their institution, agency or health science center component, but also to the community, the State of Texas, and/or at the international level has been exemplary. He also was the recipient of the President's Award from Lilly Research Laboratories of Eli Lilly and Co. and was named a Robert Wood Johnson Foundation Faculty Fellow in Health Care Finance at Johns Hopkins University. Additionally, he was selected for inclusion in several editions of Who's Who in America, Who's Who in the South and Southwest, and Who's Who in Finance and Industry. Dr. Ohsfeldt has authored numerous articles for peer-reviewed journals and co-authored "The Business of Health." He also co-edited "The Socioeconomic Characteristics of Medical Practice" and was a member of the editorial board of the Journal of Managed Care and Specialty Pharmacy. Today, he continues to work as a journal reviewer for several scholarly journals.Dr. Ohsfeldt prepared for his career by achieving a Bachelor of Science from the University of Houston in 1977, and completed his Ph.D. from the same university in 1983. Looking to the future, Dr. Ohsfeldt intends to continue working as a professor, conducting research, teaching and mentoring doctoral students.About Marquis Who's Who :Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis now publishes many Who's Who titles, including Who's Who in America , Who's Who in the World , Who's Who in American Law , Who's Who in Medicine and Healthcare , Who's Who in Science and Engineering , and Who's Who in Asia . Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com


Wiseguyreports.Com Adds “Nicotine Gum -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database The Global Nicotine Gum Market Size 2016 Industry Trend and Forecast 2022 is a professional and in-depth study on the current state of the nicotine gum industry. With the improvement of people's awareness of smoking cessation, demand for nicotine gum is increasing. In 2011, global nicotine gum production was about 5100 Million Pieces. While in 2015, it increased to about 6400 Million Pieces with an average increase rate of 5.72% during 2011-2015. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The nicotine gum market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North America, EU and Asia), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the nicotine gum industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered. In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. 1 Industry Overview of Nicotine Gum 1 1.1 Definition and Specifications of Nicotine Gum 1 1.1.1 Definition of Nicotine Gum 1 1.1.2 Specifications of Nicotine Gum 1 1.2 Classification of Nicotine Gum 2 1.2.1 2 mg/piece of Gum Dosage 2 1.2.2 4 mg/piece of Gum Dosage 3 1.3 Applications of Nicotine Gum 4 1.3.1 Withdrawal Clinics 4 1.3.2 Medical Practice 5 1.3.3 Individual Smokers 5 1.4 Industry Chain Structure of Nicotine Gum 5 1.5 Industry Overview and Major Regions Status of Nicotine Gum 5 1.5.1 Industry Overview of Nicotine Gum 5 1.5.2 Global Major Regions Status of Nicotine Gum 6 1.6 Industry Policy Analysis of Nicotine Gum 6 1.7 Industry News Analysis of Nicotine Gum 8 2 Manufacturing Cost Structure Analysis of Nicotine Gum 9 2.1 Raw Material Suppliers and Price Analysis of Nicotine Gum 9 2.1.1 Nicotine 9 2.1.2 Ion Exchange Resin 10 2.1.3 Bicarbonate 11 2.1.4 Gum Base 11 2.2 Equipment Suppliers and Contact Information of Nicotine Gum 14 2.3 Labor Cost Analysis of Nicotine Gum 15 2.4 Other Costs Analysis of Nicotine Gum 22 2.5 Manufacturing Cost Structure Analysis of Nicotine Gum 27 2.6 Manufacturing Process Analysis of Nicotine Gum 27 4 Capacity, Production and Revenue Analysis of Nicotine Gum by Regions, Types and Manufacturers 33 5 Price, Cost, Gross and Gross Margin Analysis of Nicotine Gum by Regions, Types and Manufacturers 53 6 Consumption Volume, Consumption Value and Sale Price Analysis of Nicotine Gum by Regions, Types and Applications 57 8 Major Manufacturers Analysis of Nicotine Gum 74 8.1 Novartis 74 8.1.1 Company Profile 74 8.1.2 Product Picture and Specifications 75 8.1.3 Capacity, Production, Price, Cost, Gross and Revenue 75 8.1.4 Contact Information 77 8.2 Perrigo Company 77 8.2.1 Company Profile 77 8.2.2 Product Picture and Specifications 78 8.2.3 Capacity, Production, Price, Cost, Gross and Revenue 78 8.2.4 Contact Information 80 8.3 Pharmacia 80 8.3.1 Company Profile 80 8.3.2 Product Picture 82 8.3.3 Capacity, Production, Price, Cost, Gross and Revenue 82 8.3.4 Contact Information 83 8.4 Fertin Pharma 84 8.4.1 Company Profile 84 8.4.2 Product Picture and Specifications 85 8.4.3 Capacity, Production, Price, Cost, Gross and Revenue 85 8.4.4 Contact Information 86 8.5 Revolymer 87 8.5.1 Company Profile 87 8.5.2 Product Picture and Specifications 88 8.5.3 Capacity, Production, Price, Cost, Gross and Revenue 88 8.5.4 Contact Information 89 8.6 Johnson & Johnson 90 8.6.1 Company Profile 90 8.6.2 Product Picture 91 8.6.3 Capacity, Production, Price, Cost, Gross and Revenue 91 8.6.4 Contact Information 92 8.7 Alchem International 93 8.7.1 Company Profile 93 8.7.2 Product Picture and Specifications 94 8.7.3 Capacity, Production, Price, Cost, Gross and Revenue 94 8.7.4 Contact Information 95 8.8 Cambrex Corporation 96 8.8.1 Company Profile 96 8.8.2 Product Picture 97 8.8.3 Capacity, Production, Price, Cost, Gross and Revenue 97 8.8.4 Contact Information 98 8.9 GlaxoSmithKline 99 8.9.1 Company Profile 99 8.9.2 Product Picture 100 8.9.3 Capacity, Production, Price, Cost, Gross and Revenue 100 8.9.4 Contact Information 101 8.10 Reynolds American 102 8.10.1 Company Profile 102 8.10.2 Product Picture 103 8.10.3 Capacity, Production, Price, Cost, Gross and Revenue 103 8.10.4 Contact Information 104 8.11 Dr. Reddy’s Laboratories 105 8.11.1 Company Profile 105 8.11.2 Product Picture 106 8.11.3 Capacity, Production, Price, Cost, Gross and Revenue 106 8.11.4 Contact Information 107 For more information, please visit https://www.wiseguyreports.com/reports/513731-global-nicotine-gum-market-size-2016-industry-trend-and-forecast-2022


News Article | October 28, 2016
Site: co.newswire.com

Central Florida Holistic Medical Practice Moves To Maitland, FL

Loading Medical Practice collaborators
Loading Medical Practice collaborators